Kathy Manchulenko

486 total citations
7 papers, 351 citations indexed

About

Kathy Manchulenko is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy. According to data from OpenAlex, Kathy Manchulenko has authored 7 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Immunology and Allergy. Recurrent topics in Kathy Manchulenko's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Protein purification and stability (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Kathy Manchulenko is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Protein purification and stability (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Kathy Manchulenko collaborates with scholars based in United States, Canada and United Kingdom. Kathy Manchulenko's co-authors include Ian N. Foltz, Wei Yan, Kannan Gunasekaran, Min Shen, Anne Woodward, Marc W. Retter, Heather Sweet, Teresa L. Born, Carla Forte and Michael Wittekind and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Analytical Biochemistry.

In The Last Decade

Kathy Manchulenko

6 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathy Manchulenko United States 6 281 258 82 74 25 7 351
Arlene Sereno United States 8 282 1.0× 273 1.1× 116 1.4× 103 1.4× 30 1.2× 10 393
Anca Clabbers United States 7 269 1.0× 271 1.1× 100 1.2× 112 1.5× 26 1.0× 9 402
Martin Schwill Switzerland 7 242 0.9× 201 0.8× 146 1.8× 37 0.5× 27 1.1× 8 359
Jyothsna Visweswaraiah United States 8 313 1.1× 208 0.8× 89 1.1× 97 1.3× 34 1.4× 13 471
Ankit Gupta United States 9 241 0.9× 86 0.3× 102 1.2× 64 0.9× 33 1.3× 22 370
Jenny Boström United States 5 279 1.0× 304 1.2× 113 1.4× 91 1.2× 24 1.0× 6 386
Erik D. Wold United States 8 351 1.2× 226 0.9× 158 1.9× 27 0.4× 40 1.6× 10 498
Anna Park United States 10 320 1.1× 392 1.5× 166 2.0× 101 1.4× 21 0.8× 17 514
Hanieh Khalili United Kingdom 8 173 0.6× 162 0.6× 76 0.9× 34 0.5× 34 1.4× 16 314
John J. Rhoden United States 6 142 0.5× 171 0.7× 106 1.3× 47 0.6× 61 2.4× 8 322

Countries citing papers authored by Kathy Manchulenko

Since Specialization
Citations

This map shows the geographic impact of Kathy Manchulenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Manchulenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Manchulenko more than expected).

Fields of papers citing papers by Kathy Manchulenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Manchulenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Manchulenko. The network helps show where Kathy Manchulenko may publish in the future.

Co-authorship network of co-authors of Kathy Manchulenko

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Manchulenko. A scholar is included among the top collaborators of Kathy Manchulenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Manchulenko. Kathy Manchulenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Grujic, Ognjen, Jennitte Stevens, Jennifer Weiszmann, et al.. (2017). Impact of antibody subclass and disulfide isoform differences on the biological activity of CD200R and βklotho agonist antibodies. Biochemical and Biophysical Research Communications. 486(4). 985–991. 8 indexed citations
2.
Liu, Zhi, Kannan Gunasekaran, Min Shen, et al.. (2015). A Novel Antibody Engineering Strategy for Making Monovalent Bispecific Heterodimeric IgG Antibodies by Electrostatic Steering Mechanism. Journal of Biological Chemistry. 290(12). 7535–7562. 60 indexed citations
3.
Clark, Rutilio H., Ramil F. Latypov, Jane Carter, et al.. (2014). Remediating agitation-induced antibody aggregation by eradicating exposed hydrophobic motifs. mAbs. 6(6). 1540–1550. 15 indexed citations
4.
Jenkins, David W., Sarah J. Ross, Margaret H. Veldman-Jones, et al.. (2012). MEDI0639: A Novel Therapeutic Antibody Targeting Dll4 Modulates Endothelial Cell Function and Angiogenesis In Vivo. Molecular Cancer Therapeutics. 11(8). 1650–1660. 47 indexed citations
5.
Rathanaswami, Palaniswami, et al.. (2011). Kinetic analysis of unpurified native antigens available in very low quantities and concentrations. Analytical Biochemistry. 414(1). 7–13. 8 indexed citations
6.
Gunasekaran, Kannan, Min Shen, Carla Forte, et al.. (2010). Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects. Journal of Biological Chemistry. 285(25). 19637–19646. 213 indexed citations
7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026